Laurus Labs Ltd.

View in App
377.55 -1.70 ▼-0.5%

05 December 2023, 02:56:57 PM
Volume: 1,077,709

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lauruslabs.com
Market Cap 20,361.00 Cr.
Enterprise Value(EV) 22,446.08 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 6.83 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 55.36 Trailing Twelve Months Ending 2023-09
Industry PE 38.73 Trailing Twelve Months Ending 2023-09
Book Value / Share 74.81 Trailing Twelve Months Ending 2023-09
Price to Book Value 5.05 Calculated using Price: 378.00
Dividend Yield 0.53 Period Ending 2023-03
No. of Shares Subscribed 53.87 Cr. 538,650,925 Shares
FaceValue 2
About Laurus Labs Ltd.
Laurus Labs offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

Laurus Labs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Laurus Labs Ltd. Performance

View details >>
1 Day
-0.45%
1 Week
+1.29%
1 Month
+3.64%
3 Month
-4.25%
6 Month
+9.10%
1 Year
-10.87%
2 Year
-26.17%
5 Year
+391.41%
10 Year

Laurus Labs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 14.47 18.65 18.12 11.97 6.19 15.39 45.15 28.05 21.63
Return on Capital Employed (%) 13.74 16.35 16.52 13.68 8.22 14.14 39.82 25.97 22.97
Return on Assets (%) 4.31 6.61 8.05 6.04 3.00 7.34 20.87 13.09 10.89

Laurus Labs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 722 857 1,330 1,483 1,558 1,770 2,598 3,351 4,038 4,030
Non Curr. Liab. 364 428 132 174 295 214 693 928 1,179 1,069
Curr. Liab. 802 884 1,121 1,307 1,424 1,692 2,457 2,681 2,432 2,945
Minority Int. 3 8 11 13
Equity & Liab. 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968 7,660 8,058
Non Curr. Assets 1,024 1,166 1,444 1,716 1,815 1,864 2,676 3,623 4,199 4,390
Curr. Assets 862 1,003 1,140 1,248 1,463 1,812 3,075 3,345 3,462 3,668
Misc. Exp. not W/O 2
Total Assets 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968 7,660 8,058

Laurus Labs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 1,327 1,778 1,905 2,056 2,292 2,832 4,814 4,936 6,041 5,332
Other Income 34 4 33 29 16 6 24 15 6 9
Total Income 1,361 1,782 1,938 2,085 2,308 2,838 4,837 4,951 6,047 5,340
Total Expenditure -1,131 -1,415 -1,497 -1,643 -1,936 -2,267 -3,263 -3,513 -4,448 -4,288
PBIDT 229 367 441 443 372 570 1,574 1,438 1,598 1,052
Interest -101 -111 -100 -80 -88 -90 -68 -102 -165 -177
Depreciation -62 -86 -106 -125 -164 -187 -205 -251 -324 -355
Taxation 2 -35 -44 -70 -26 -38 -317 -251 -312 -141
Exceptional Items
PAT 68 134 191 168 94 255 984 832 797 378
Minority Interest 0 -5 -3 -4
Share Associate 0 0 -1 0 -3 -6
Other Related Items -6
Consolidated Net Profit 68 134 190 168 94 255 984 828 785 368
Adjusted EPS 2 4 4 3 2 5 18 15 15 7

Laurus Labs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 121 -65 182 332 342 298 347 733 911 994
Cash Fr. Inv. -312 -397 -312 -289 -384 -253 -221 -941 -914 -996
Cash Fr. Finan. 203 486 103 -54 42 -45 -128 255 30 -27
Net Change 12 24 -27 -10 1 0 -1 47 27 -29
Cash & Cash Eqvt 15 40 13 2 3 3 2 48 75 46

Laurus Labs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 27.30 27.27 27.27 27.27 27.27 27.20 27.20 27.20 27.20
Public 72.70 72.73 72.73 72.73 72.73 72.80 72.80 72.80 72.80
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.04 0.04 0.04 0.04 0.04

Laurus Labs Ltd. Announcements

View details >>
Fri, 24 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Laurus Labs Limited has informed the Exchange about Schedule of meet
Fri, 24 Nov 2023
Investor Presentation
Laurus Labs Limited has informed the Exchange about Investor Presentation
Thu, 23 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Laurus Labs Limited has informed the Exchange about Schedule of meet

Laurus Labs Ltd. Technical Scans

View details >>
Mon, 04 Dec 2023
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 5 Years High Increase in 5 Years
Closing Near 50 SMA Closing Near 50 SMA
Closing Near 100 SMA Closing Near 100 SMA

Laurus Labs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,466.10 1,235.75 +0.4%
Divi's Laboratories Ltd. 100,787.80 3,731.00 -1.8%
Cipla Ltd. 98,218.21 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. 95,898.45 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. 80,842.20 5,565.65 -1.0%
Mankind Pharma Ltd. 76,792.80 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. 72,137.95 2,097.10 -1.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.68 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-09 28.44 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.84 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.91 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.08 2,097.10 -1.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.95 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-09 3.96 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.44 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.76 2,097.10 -1.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,097.10 -1.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,097.10 -1.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,097.10 -1.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,097.10 -1.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.75 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,731.00 -1.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,219.05 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,754.90 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,565.65 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,955.00 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,097.10 -1.7%

Laurus Labs Ltd. FAQ's

What is Laurus Labs share price?
Can I buy Laurus Labs shares now?
What is the Dividend Yield of Laurus Labs?
What is the Market Cap of Laurus Labs?
What are the key metrics to analyse Laurus Labs?
What is the 52 Week High and Low of Laurus Labs?
What is the trend of Laurus Labs share price?